CRIA faculty members comprise a dynamic research community at UB who make news with their breakthroughs in studying the causes, consequences and biology of addiction.
BUFFALO, N.Y. — Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses?
As nonprescription use of Ritalin increases among young adults, researchers at UB's Clinical and Research Institute on Addictions warn that such use may cause irreversible structural changes in certain areas of the brain.
An innovative, cost-effective program in Western New York provides medication-assisted treatment to opioid use disorder patients in emergency departments (EDs) and rapidly transitions them into long-term treatment all within about 48 hours.
Scientists at UB’s Clinical and Research Institute on Addictions recently received more than $4 million in grants from the National Institutes of Health to study the effects of drinking, smoking and marijuana use during pregnancy.
BUFFALO, N.Y — A University at Buffalo graduate student studying how heroin changes cells in the brain has received a prestigious award from the National Institutes of Health.
Study funded by University of Rochester Center for AIDS Research is part of a concerted strategy to improve substance use disorder outcomes and decrease HIV infections.
Researchers at UB's Clinical and Research Institute on Addictions will work with the state Office of Alcoholism and Substance Abuse Services to assess what risks may occur for people with alcohol use disorder who use prescription painkillers.
McGill University professor George Weisz will deliver the keynote address to open a two-day UB symposium that will bring together leading experts from around the world to explore addiction as a treatable, chronic disease.
UB has reorganized its Research Institute on Addictions to foster a multidisciplinary approach to addressing the crisis of substance use disorders, with an emphasis on combating the opiate addiction epidemic gripping the region and nation.
A new class of drug targets that has attracted attention for its potential to treat psychiatric and other diseases has now been shown to curb drug-seeking behaviors.
UB’s Clinical and Research Institute on Addictions (CRIA) is a long-standing national leader in the study of alcohol and substance abuse. For nearly 50 years, CRIA has conducted groundbreaking research on significant addiction issues, including:
Part of UB’s Downtown Campus, CRIA is a key contributor to UB’s reputation for research excellence and a proud member of the Buffalo Niagara Medical Campus.
